Current Issue


Intermittent fasting may be effective weight loss strategy in patients with type 2 diabetes

A systematic review and meta-analysis of seven studies found that intermittent fasting induced a greater decrease in body weight compared to regular diet but was not associated with any greater reduction in HbA1c levels.

Surgical, drug treatments have similar outcomes in patients with vitreous hemorrhage from proliferative diabetic retinopathy

A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.

Biomarker score predicts heart failure risk with diabetes and prediabetes

The score, which was based on cardiac troponin, N-terminal pro-B-type natriuretic peptide, C-reactive protein, and electrocardiography, could be used to target specific therapies to the highest-risk patients, study authors said.

MKSAP quiz: Treatment escalation

This month's quiz asks readers to evaluate a woman with type 2 diabetes who has not been successful in reaching her HbA1c goal with lifestyle modifications and multiple medications.

Spotlight on COVID-19 and diabetes

Recent articles looked at the risks of COVID-19 in patients with diabetes, optimal hospital treatment for those with both conditions, and new-onset diabetes in patients with COVID-19.

In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors

A cohort study's finding of increased risk of diabetic ketoacidosis with sodium-glucose cotransporter-2 (SGLT2) inhibitors is relevant to clinical decision making, but not definitive given the limitations of observational research, an ACP Journal Club commentary said.

Extended-release metformin recalled due to nitrosamine impurities

A company recently expanded a recall of metformin hydrochloride extended-release tablets USP due to excess amounts of N-nitrosodimethylamine.